MedPath
NMPA Approval

归脾丸

国药准字Z44020040

April 9, 2024

Drug Information

归脾丸

丸剂(水蜜丸)

中药

April 9, 2024

Company Information

Applicant Company

广州市黄埔区云埔一路32号

Manufacturing Company

广州市黄埔区云埔一路32号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

归脾丸 - NMPA 批准文号 | MedPath